AOP-Wiki

AOP ID and Title:

AOP 376: Androgen receptor agonism leading to male-biased sex ratio
Short Title: AR agonism leading to male-biased sex ratio

Graphical Representation

Authors

Kelvin J. Santana Rodriguez, Oak Ridge Institute for Science and Education, U.S. Environmental Protection Agency, Great Lakes Ecology Divison, Duluth, MN

Status

Author status OECD status OECD project SAAOP status
Under development: Not open for comment. Do not cite

Abstract

This adverse outcome pathway links  androgen receptor agonism in teleost fish during gonadogenesis to male-biased sexual differentiation and successively, reduced population sustainability. Sex determination in teleost fishes is highly plastic; it can be both genetically and environmentally driven which can also make them very sensitive to environmental pollutants. Exogenous hormones are of ecological concern because they have the potential to alter gonad development and sex differentiation. Androgens play a crucial role in sex differentiation, sexual maturation, and spermatogenesis in vertebrates and their modes of action are mediated via androgen receptors (ARs). Like many steroid hormones, androgens acts by entering the cell and forming a complex with a its hormone receptor allowing it to enter the nucleus where it can bind to specific short DNA sequences (Androgen Responsive Elements) and serve as transcription factors of androgen mediated genes involved in the male differentiation pathway. Many studies have shown that administration during early development in some teleost species, sex steroids can induce complete gonadal sex inversion. This can result in male biased sex ratios which can heavily impact population fitness and survival given that the lack of females can reduce the reproductive production of the population.

Summary of the AOP

Events

Molecular Initiating Events (MIE), Key Events (KE), Adverse Outcomes (AO)

Sequence Type Event ID Title Short name
1 MIE 25 Agonism, Androgen receptor Agonism, Androgen receptor
2 KE 1790 Increased, Differentiation to Testis Increased, Differentiation to Testis
3 KE 1791 Increased, Male Biased Sex Ratio Increased, Male Biased Sex Ratio
4 AO 360 Decrease, Population trajectory Decrease, Population trajectory

Key Event Relationships

Upstream Event Relationship Type Downstream Event Evidence Quantitative Understanding
Agonism, Androgen receptor adjacent Increased, Differentiation to Testis
Increased, Differentiation to Testis adjacent Increased, Male Biased Sex Ratio
Increased, Male Biased Sex Ratio adjacent Decrease, Population trajectory
Agonism, Androgen receptor non-adjacent Increased, Male Biased Sex Ratio

Stressors

Name Evidence
17beta-Trenbolone High
Chemical:33664 17-Methyltestosterone Moderate
5alpha-Dihydrotestosterone Moderate
Methyldihydrotestosterone Moderate
11-Keto-testosterone Low

Overall Assessment of the AOP

See details below.

Domain of Applicability

Life Stage Applicability
Life Stage Evidence
Development High
Taxonomic Applicability
Term Scientific Term Evidence Links
zebra fish Danio rerio High NCBI
medaka Oryzias latipes Low NCBI
fathead minnow Pimephales promelas Low NCBI
channel catfish Ictalurus punctatus Low NCBI
Oreochromis niloticus Oreochromis niloticus Low NCBI
Chinook salmon Oncorhynchus tshawytscha Low NCBI
Sex Applicability
Sex Evidence
Unspecific High

Life Stage

The life stage applicable to this AOP is developing embryos and juveniles prior to- or during the gonadal developmental stage. This AOP is not applicable to sexually differentiated adults. 

Sex

The molecular initiation event for this AOP occurs prior to gonad differentiation. Therefore, this AOP is only applicable to sexually undifferentiated individuals

Taxonomic

The taxonomic applicability of this AOP is the class Osteichthyes. However phylogenetic analysis has shown that the ar genes appear to be specific to jawed vertebrates (Gnathostomata), since no ar gene has been reported from Agnatha (Thornton 2001; Hossain et al 2008). Therefore, because all key events in the present AOP can be applicable to most non-mammalian vertebrates, it is probable that this AOP could be relevant to amphibians, reptiles and birds as well.  Though, the outcomes might differ due to species-specific differences. 

Essentiality of the Key Events

Support for the essentiality of several of the Key Events in the AOP was provided mainly in combination of in vivo and in vitro studies of androgen receptor agonist and antagonist exposures during the critical period of sexual differentiation.

Golan & Levavi-Sivian 2014 exposed genetically female Nile tilapia (Oreochromis niloticus) to 17-a-methyltestosterone (MT) and dihydrotestosterone (DHT), two well-known androgen receptor agonisms that induces the male differentiation pathway and a dose dependent male biased sex ratio (downstream key events). However, when these are combined with androgen antagonist Flutamide, the sex inversion potency of androgen is reduced in a dose-dependent manner. The decrease in sex inversion efficiency caused by flutamide is due to the direct blocking of the androgen binding to its androgen receptor. Therefore, this suggest that androgen receptor agonism ligand binding is required for the subsequent key events to occur.

Crowder et al., 2018 generated zebrafish with a mutation in the ar gene (aruab105/105) and the resulting mutants developed ovaries and displayed female secondary sexual characteristics. The small percentage of mutants that developed as males displayed female secondary sexual characteristics with structurally disorganized testes, and were unable to produce normal levels of sperm. This demonstrates that the AR is required for proper testis development and fertility. This supports the essentiality for the androgen receptor agonism for the testis differentiation pathway to proceed.

In a similar study with zebrafish, Yu et al. 2018 generate ar gene mutant line using CRISPR/Cas9 technology. The resulting showed that the number of female offspring was increased and the resulting ar-null males had female secondary sex characteristics and were infertile due to defective spermatogenesis. This study supports the essentiality for the ar agonism for the development of testis and subsequently a male biased sex ratio. 

 

Key Event

Evidence

Essentiality/Assessment

Agonism, Androgen

moderate

There is good evidence from a sex inversion treatment via the direct blocking of AR using androgen antagonist that support the specificity of androgen receptor agonism for the subsequent key events to occur.  

Differentiation to Testis

moderate

Biological plausibility provides strong support for the essentiality of this event for the subsequent key events to occur.

Male Biased Sex Ratio

moderate

Breeding females (and both sexes) are necessary for population sustainability. A male biased sex population suggests a reduced offspring production and consequentially reduced population sustainability.

Population Sustainability

weak

 

 

 

Weight of Evidence Summary

Biological Plausibility

The biological plausibility linking androgen receptor agonism through the increased differentiation to testis is very solid. Actions of androgens are mediated by the androgen receptor. The Androgen Receptor (AR) is part of the nuclear receptor superfamily. ARs are ligand-dependent transcription factors and contain a highly conserved DNA-binding domain (DBD) and a moderately well conserved ligand-binding domain (LBD) (Hossain et al., 2008). Steroid hormones such as androgens acts by entering the cell and forming a complex with a its hormone receptor. After ligand binding, AR monomers undergo conformational change, dissociate from chaperone proteins, dimerize, and bind coactivator proteins (Bohen et al., 1995; Pratt and Toft, 1997). After this, the complex is translocated to the nucleus where it can bind to specific short DNA sequences (Androgen Responsive Elements) and serve as transcription factors of androgen mediated genes (Harbott et al., 2009). During sexual development, endogenous androgen can therefore induce the upregulation of many genes involved in the male developmental pathway.

The direct link between increased differentiation to testis leading to a male biased sex ratio is also well supported by biological plausibility. If the conditions that favored a male producing phenotype (in this case, exposure to androgens) overlap with the critical period of sex differentiation in a given population, it is reasonable that more phenotypic males will be produced (Orn et al., 2003; Seki et al., 2004; Bogers et al., 2006; Morthorst et al., 2010; Baumann et al., 2014; Golan & Levavi-Sivian 2014). Therefore, persistence of androgen exposure for repeated or prolong periods of times within the habitat of given fish species, can result in a male-biased population. Empirical evidence supporting the direct link between male biased population and a reduced population sustainability in fish species is lacking. However, increasing or permanent biased sex ratios can definitely have significant effects in sustainable fish populations (Marty et al. 2017). A male-biased sex ratio already suggests that the number of breeding females is reduced. If the male-biased sex ratio persists and/or increases over time, the offspring production for such population could eventually decrease and consequently, population productivity would be reduced (Brown et al. 2015; Grayson et al. 2014).

Concordance of Dose Response

The concentration-dependence of the key event responses with regard to the concentration of androgens has been established in vivo for some key events in the AOP. In general, effects on downstream key events occurred at concentrations equal to or greater than those at which upstream events occurred. Few studies that looked at multiple key events on this AOP were considered to be stronger support when evaluating the dose response relationship between key events. However, binding to the androgen receptor (the MIE) was not directly measured in any of the in vivo studies as this is often measured with in vitro studies. In fish, phenotypic masculinization of females has been used as an indirect measurement of in vivo androgen receptor agonism. However, in this case/aop, androgen receptor agonism is occurring prior to sexual differentiation and the resulting “phenotypic measurement” for the in vivo study is already considered as a separate downstream key event. Therefore, because support for the upstream key event is done in a different system (in vitro) than for the downstream key events (in vivo) , support for the dose concordance of the androgen receptor agonism (upstream) is done via in vitro studies that targeted the specific steroids used on the in vivo studies of the downstream key event.

  1. Concentration depended androgen receptor agonism (in vitro)
  • COS Whole Cell Binding Assay with fathead minnow AR (fhAR) were used in competitive binding experiments testing several natural and synthetic steroids, some of which are environmental contaminants, such as R188, 17B-trenbolone , and 17a-trenbolone. All showed a concentration dependent displacement of [3H]R1881 binding proving to be high affinity ligands for the fmAR. (Wilson et al., 2004).
    •  The synthetic steroids, R1881 and methytestosterone, had the highest affinities of all the chemicals tested with IC50 values of about 1.6 nM, followed by the synthetic steroids 17α- and 17β-trenbolone with IC50 values of about 8 and 16 nM, respectively.
    • Of the natural steroids, dihydrotestosterone was the strongest competitor with an IC50 of about 20 nM. The IC50 for the fish specific androgen, 11- ketotestosterone, was approximately 40 nM, followed by both testosterone and androstenedione at about 100 nM
  • Important to note that all of the above steroids tested were used in the in vivo studies that were selected to support this AOP demonstrating that all bound to the fhAR with a higher affinity than 11- ketotestosterone.
  1. Concentration dependent increased differentiation to testes:
  • Studies with Zebrafish (Danio rerio) exposed to 17β-trenbolone and Japanese medaka (Oryzias latipes) resulted in masculinization at different biological effect levels in a concentration-dependent manner as evidenced from a significantly increased maturity of testes (Orn et al., 2006; Morthorst et al., 2010; Baumann et al., 2014)) for some studies, this was determined ether by the abundance of spermatozoa and/or by the area of the testis.
  1. Concentration depended increased male biased sex ratio:
  • Zebrafish (Danio rerio) exposed to different concentrations of 17β-trenbolone and Dihydrotestosterone lead to increased number of males in a dose-dependent way (Orn et al., 2003; Morthorst et al., 2010; Baumann et al., 2013; Baumann et al., 2014)
  1. Concentration depended decline in population trajectory:
    • Modeled population trajectories show a concentration-dependent reduction in projected population size (Brown et al 2015, Miller et al. 2021?) based strongly on the ratio of male to female. Population-level effects have not been measured directly based on androgen receptor agonism. 

Dose Concordance Table

Temporal concordance

 

Consistency

We are aware of no cases where the pattern of key events described was observed without also observing a significant impact on male sex ratios in teleost fish species. There are cases however, in which exposure to aromatizable androgens such as Methyltestosterone may lead to feminization of fish. This is due in part by excess aromatizable androgens available that can be converted to E2 and favor a female developmental pathway.

The adverse outcome is not specific to this AOP. Many of the key events included in this AOP overlap with AOPs linking other molecular initiating events during the period of development (ie. Aromatase inhibition, AOP 346) to male biased sex ratios.

Uncertainties, inconsistencies, and data gaps

It’s important to note that the use of aromatizable instead of non-aromatizable androgens for sex reversals exposures can lead to excess aromatizable androgens being converted to E2 and inducing a female developmental pathway. Chinook salmon (Oncorhynchus tshawytscha) exposed to Methyltestosterone showed a concentration dependent increase in percentage of males where 100% males were obtained at doses 400 ug/L. but at higher concentrations, the percentage of males decreased and at 10,000ug/L. the percentage of males reduced to 79.4%. (Peferrer & Donaldson, 1993).

However, there have been similar cases to the latter but with the use of non-aromatizable androgens such as Dihydrotestosterone in which the primary cause of this feminization is not clear yet. Bogers et al. 2006 exposed Fathead minnow (Pimephales promelas) to Dihydrotestosterone where fish exposed to 0.1 μg/L all had developed testes with one fish showing mixed sex (testis–ova). Exposure to 0.32 μg/L resulted in 80% males and 20% mixed gonads. But at 1.0ug/L  the percentage of males reduced to 40% (40% female, 10% undifferentiated and 10% mixed gonad). Additionally, it has been reported that oral administration of non aromatizable androgen dihydrotestosterone to sexually undifferentiated Channel Catfish (Ictalurus punctatus) resulted in all female populations (Davis et al. 1992).

Quantitative Consideration

Based on the evidence reviewed during development of this AOP, quantitative understanding of the KERs is limited at this time.

Considerations for Potential Applications of the AOP (optional)

Sex ratios can be a useful endpoint in risk and hazard assessment of chemicals. In July 2011, the Fish Sexual Development Test (FSDT) has officially been adopted as OECD test guideline no. 234 for the detection of EDCs within the OECD conceptual framework at level 4 (OECD, 2011b). The Fish Sexual Development Test covers endocrine disruption during the developmental period of sexual differentiation of particularly zebrafish and uses gonadal differentiation and sex ratio as endocrine disruption-associated endpoints. Therefore, this AOP can provide additional support to the use of alternative measurements in this type of tests when screening for sex steroid hormones or any other type of EDC affecting androgen receptors.

References

Baumann, L., Holbech, H., Keiter, S., Kinnberg, K. L., Knörr, S., Nagel, T., & Braunbeck, T. (2013). The maturity index as a tool to facilitate the interpretation of changes in vitellogenin production and sex ratio in the Fish Sexual Development Test. Aquatic toxicology (Amsterdam, Netherlands), 128-129, 34–42.

Baumann, L., Knörr, S., Keiter, S., Nagel, T., Rehberger, K., Volz, S., Oberrauch, S., Schiller, V., Fenske, M., Holbech, H., Segner, H., & Braunbeck, T. (2014). Persistence of endocrine disruption in zebrafish (Danio rerio) after discontinued exposure to the androgen 17β-trenbolone. Environmental toxicology and chemistry, 33(11), 2488–2496. https://doi.org/10.1002/etc.2698

Bogers, R., De Vries-Buitenweg, S., Van Gils, M., Baltussen, E., Hargreaves, A., van de Waart, B., De Roode, D., Legler, J., & Murk, A. (2006). Development of chronic tests for endocrine active chemicals. Part 2: an extended fish early-life stage test with an androgenic chemical in the fathead minnow (Pimephales promelas). Aquatic toxicology (Amsterdam, Netherlands), 80(2), 119–130. https://doi.org/10.1016/j.aquatox.2006.07.020

Crowder, C. M., Lassiter, C. S., & Gorelick, D. A. (2018). Nuclear Androgen Receptor Regulates Testes Organization and Oocyte Maturation in Zebrafish. Endocrinology, 159(2), 980–993. https://doi.org/10.1210/en.2017-00617

Davis, K. B., Goudie, C. A., Simco, B. A., Tiersch, T. R., & Carmichael, G. J. (1992). Influence of dihydrotestosterone on sex determination in channel catfish and blue catfish: period of developmental sensitivity. General and comparative endocrinology, 86(1), 147–151. https://doi.org/10.1016/0016-6480(92)90136-8

Davis, K. B., Simco, B. A., Goudie, C. A., Parker, N. C., Cauldwell, W., & Snellgrove, R. (1990). Hormonal sex manipulation and evidence for female homogamety in channel catfish. General and comparative endocrinology, 78(2), 218–223. https://doi.org/10.1016/0016-6480(90)90008-a

Dušková, M., & Pospíšilová, H. (2011). The role of non-aromatizable testosterone metabolite in metabolic pathways. Physiological research, 60(2), 253–261. https://doi.org/10.33549/physiolres.932080

Galvez, J., Mazik, P., Phelps, R., Mulvaney, D. (1995) Masculinization of Channel Catfish Ictalurus punctatus by Oral Administration of Trenbolone Acetate. World Aquaculture Society, 26(4), 378-383. https://doi.org/10.1111/j.1749-7345.1995.tb00832.x

Golan, M., & Levavi-Sivan, B. (2014). Artificial masculinization in tilapia involves androgen receptor activation. General and comparative endocrinology, 207, 50–55. https://doi.org/10.1016/j.ygcen.2014.04.026

Harbott, L. K., Burmeister, S. S., White, R. B., Vagell, M., & Fernald, R. D. (2007). Androgen receptors in a cichlid fish, Astatotilapia burtoni: structure, localization, and expression levels. The Journal of comparative neurology, 504(1), 57–73. https://doi.org/10.1002/cne.21435

Hossain, M. S., Larsson, A., Scherbak, N., Olsson, P. E., & Orban, L. (2008). Zebrafish androgen receptor: isolation, molecular, and biochemical characterization. Biology of reproduction, 78(2), 361–369. https://doi.org/10.1095/biolreprod.107.062018

Kemppainen, J. A., Langley, E., Wong, C. I., Bobseine, K., Kelce, W. R., & Wilson, E. M. (1999). Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Molecular endocrinology (Baltimore, Md.), 13(3), 440–454. https://doi.org/10.1210/mend.13.3.0255

Larsen, M. G., & Baatrup, E. (2010). Functional behavior and reproduction in androgenic sex reversed zebrafish (Danio rerio). Environmental toxicology and chemistry, 29(8), 1828–1833. https://doi.org/10.1002/etc.214

Leet, J. K., Gall, H. E., & Sepúlveda, M. S. (2011). A review of studies on androgen and estrogen exposure in fish early life stages: effects on gene and hormonal control of sexual differentiation. Journal of applied toxicology : JAT, 31(5), 379–398. https://doi.org/10.1002/jat.1682

Martyniuk, C. J., & Denslow, N. D. (2012). Exploring androgen-regulated pathways in teleost fish using transcriptomics and proteomics. Integrative and comparative biology, 52(5), 695–704. https://doi.org/10.1093/icb/ics072

Morthorst, J. E., Holbech, H., & Bjerregaard, P. (2010). Trenbolone causes irreversible masculinization of zebrafish at environmentally relevant concentrations. Aquatic toxicology (Amsterdam, Netherlands), 98(4), 336–343. https://doi.org/10.1016/j.aquatox.2010.03.008

Örn, S., Holbech, H., & Norrgren, L. (2016). Sexual disruption in zebrafish (Danio rerio) exposed to mixtures of 17α-ethinylestradiol and 17β-trenbolone. Environmental toxicology and pharmacology, 41, 225–231. https://doi.org/10.1016/j.etap.2015.12.010

Orn, S., Holbech, H., Madsen, T. H., Norrgren, L., & Petersen, G. I. (2003). Gonad development and vitellogenin production in zebrafish (Danio rerio) exposed to ethinylestradiol and methyltestosterone. Aquatic toxicology (Amsterdam, Netherlands), 65(4), 397–411. https://doi.org/10.1016/s0166-445x(03)00177-2

Orn, S., Yamani, S., & Norrgren, L. (2006). Comparison of vitellogenin induction, sex ratio, and gonad morphology between zebrafish and Japanese medaka after exposure to 17alpha-ethinylestradiol and 17beta-trenbolone. Archives of environmental contamination and toxicology, 51(2), 237–243. https://doi.org/10.1007/s00244-005-0103-y

Piferrer, F., Baker, I. J., & Donaldson, E. M. (1993). Effects of natural, synthetic, aromatizable, and nonaromatizable androgens in inducing male sex differentiation in genotypic female chinook salmon (Oncorhynchus tshawytscha). General and comparative endocrinology, 91(1), 59–65. https://doi.org/10.1006/gcen.1993.1104

Seki, M., Yokota, H., Matsubara, H., Maeda, M., Tadokoro, H., & Kobayashi, K. (2004). Fish full life-cycle testing for androgen methyltestosterone on medaka (Oryzias latipes). Environmental toxicology and chemistry, 23(3), 774–781. https://doi.org/10.1897/03-26

Shi, W. J., Jiang, Y. X., Huang, G. Y., Zhao, J. L., Zhang, J. N., Liu, Y. S., Xie, L. T., & Ying, G. G. (2018). Dydrogesterone Causes Male Bias and Accelerates Sperm Maturation in Zebrafish ( Danio rerio). Environmental science & technology, 52(15), 8903–8911. https://doi.org/10.1021/acs.est.8b02556

Swerdloff, R. S., & Wang, C. (1998). Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent. Bailliere's clinical endocrinology and metabolism, 12(3), 501–506. https://doi.org/10.1016/s0950-351x(98)80267-x

Thornton J. W. (2001). Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proceedings of the National Academy of Sciences of the United States of America, 98(10), 5671–5676. https://doi.org/10.1073/pnas.091553298

Wilson, V. S., Cardon, M. C., Thornton, J., Korte, J. J., Ankley, G. T., Welch, J., Gray, L. E., Jr, & Hartig, P. C. (2004). Cloning and in vitro expression and characterization of the androgen receptor and isolation of estrogen receptor alpha from the fathead Minnow (Pimephales promelas). Environmental science & technology, 38(23), 6314–6321. https://doi.org/10.1021/es049771j

Yu, G., Zhang, D., Liu, W., Wang, J., Liu, X., Zhou, C., Gui, J., & Xiao, W. (2018). Zebrafish androgen receptor is required for spermatogenesis and maintenance of ovarian function. Oncotarget, 9(36), 24320–24334. https://doi.org/10.18632/oncotarget.24407

 

 

Appendix 1

List of MIEs in this AOP

Event: 25: Agonism, Androgen receptor

Short Name: Agonism, Androgen receptor

Key Event Component

Process Object Action
androgen receptor activity androgen receptor increased

AOPs Including This Key Event

Stressors

Name
17beta-Trenbolone
Spironolactone
5alpha-Dihydrotestosterone

Biological Context

Level of Biological Organization
Molecular

Evidence for Perturbation by Stressor

Overview for Molecular Initiating Event

Characterization of chemical properties: Androgen receptor binding chemicals can be grouped into two broad structural domains, steroidal and non-steroidal (Yin et al. 2003). Steroidal androgens consist primarily of testosterone and its derivatives (Yin et al. 2003). Many of the non-steroidal AR binding chemicals studied are derivatives of well known non-steroidal AR antagonists like bicalutamide, hydroxyflutamide, and nilutamide (Yin et al. 2003). Nonetheless, a number of QSARs and SARs that consider AR binding of both these pharmaceutical agents as well as environmental chemicals have been developed (Waller et al. 1996; Serafimova et al. 2002; Todorov et al. 2011; Hong et al. 2003; Bohl et al. 2004). However, it has been shown that very minor structural differences can dramatically impact function as either an agonist or antagonist (Yin et al. 2003; Bohl et al. 2004; Norris et al. 2009), making it difficult at present to predict agonist versus antagonist activity based on chemical structure alone.

In vivo considerations: A variety of steroidal androgens can be converted to estrogens in vitro through the action of cytochrome P450 19 (aromatase). Structures subject to aromatization may behave in vivo as estrogens despite exhibiting potent androgen receptor agonism in vitro.

5alpha-Dihydrotestosterone

Chemical is a non-aromatizable androgen.

Domain of Applicability

Taxonomic Applicability
Term Scientific Term Evidence Links
fathead minnow Pimephales promelas High NCBI
medaka Oryzias latipes High NCBI
Life Stage Applicability
Life Stage Evidence
Adult, reproductively mature High
Sex Applicability
Sex Evidence
Female High

Taxonomic applicability: Androgen receptor orthologs are primarily limited to vertebrates (Baker 1997; Thornton 2001; Eick and Thornton 2011; Markov and Laudet 2011). Therefore, this MIE would generally be viewed as relevant to vertebrates, but not invertebrates.

Key Event Description

Site of action: The molecular site of action is the ligand binding domain of the AR. This particular key event specifically refers to interaction with nuclear AR.  Downstream KE responses to activation of membrane ARs may be different. The cellular site of action for the molecular initiating event is undefined.

Responses at the macromolecular level: Binding of a ligand, including xenobiotics that act as AR agonists, to the cytosolic AR mediates a conformational shift that facilitates dissociation from accompanying heat shock proteins and dimerization with another AR (Prescott and Coetzee 2006; Claessens et al. 2008; Centenera et al. 2008). Homodimerization unveils a nuclear localization sequence, allowing the AR-ligand complex to translocate to the nucleus and bind to androgen-response elements (AREs) (Claessens et al. 2008; Cutress et al. 2008). This elicits recruitment of additional transcription factors and transcriptional activation of androgen-responsive genes (Heemers and Tindall 2007).

AR paralogs:

  • Most vertebrates have a single gene coding for nuclear AR. However, most fish have two AR genes (AR-A, AR-B) as a result of a whole genome duplication event after the split of Acipenseriformes from teleosts but before the divergence of Osteoglossiformes (Douard et al. 2008).
  • AR-B has been lost in Cypriniformes, Siluriformes, Characiformes, and Salmoniformes (Douard et al. 2008).
  • In Percomorphs, AR-B has accumulated significant substitutions in the both ligand binding and DNA binding domains (Douard et al. 2008).
  • Differential ligand selectivity and subcellular localization has been reported for AR paralogs in some fish species (e.g., Bain et al. 2015), but the difference is not easily generalized based on available data in the literature. 

How it is Measured or Detected

Measurement/detection:

  • In vitro methods:
    • OECD Test No. 458: Stably transfected human androgen receptor transcriptional activation assay for detection of androgen agonists and antagonists has been reviewed and validated by OECD and is well suited for detection of this key event (OECD 2016).
    • Binding to the androgen receptor can be directly measured in cell free systems based on displacement of a radio-labeled standard (generally testosterone or DHT) in a competitive binding assay (e.g., (Olsson et al. 2005; Sperry and Thomas 1999; Wilson et al. 2007; Tilley et al. 1989; Kim et al. 2010).
    • Cell based transcriptional activation assays are typically required to differentiate agonists from antagonists, in vitro. A number of reporter gene assays have been developed and used to screen chemicals for AR agonist and/or antagonist activity (e.g., (Wilson et al. 2002; van der Burg et al. 2010; Mak et al. 1999; Araki et al. 2005).
    • Expression of androgen responsive proteins like spiggin in primary cell cultures has also been used to detect AR agonist activity (Jolly et al. 2006).
  • In vivo methods
    • In fish, phenotypic masculinization of females has frequently been used as an indirect measurement of in vivo androgen receptor agonism.
      • Development of nuptial tubercles, a dorsal fatpad, and a characteristic banding pattern has been observed in female fathead minnows exposed to androgen agonists (Ankley et al. 2003; Jensen et al. 2006; Ankley et al. 2010; LaLone et al. 2013; OECD 2012).
      • Anal fin elongation in female western mosquitofish (Gambusia affinis) has similarly been viewed as evidence of AR activation (Raut et al. 2011; Sone et al. 2005).
      • In medaka, development of papillary processes, which normally only appear on the second to seventh or eighth fin aray of the anal fin, has also been used as an indirect measure of androgen receptor agonism (OECD 2012).
      • Production of the nest building glue, spiggin, in three female 3-spined sticklebacks (Gasterosteus aculeatus) has also been well documented as an indicator of androgen receptor agonism (Jakobsson et al. 1999; Hahlbeck et al. 2004). Quantification of the spiggin protein in exposed female 3-spined stickleback or green fluorescence protein expression in a transgenic spg1-gfp medaka line (Sébillot et al. 2014) can be used to detect androgen receptor agonism.
  • High Throughput Screening
    • ​Measures of AR agonism have been included in high throughput screening programs, such as US EPA's Toxcast program. Toxcast assays relevant for screening chemicals for their ability to bind and/or activate the AR include:
      • ATG_AR_TRANS A cell based assay that can differentiate agonism from antagonism
      • NVS_NR_hAR A cell free assay using recombinant human AR. Can detect binding, but cannot distinguish agonism from antagonism.
      • NVS_NR_rAR A cell free assay using recombinant rat AR. Can detect binding, but cannot distinguish agonism from antagonism.
      • OT_AR_ARELUC_AG_1440 A cell based assay that measures expression of a reporter gene under control of androgen-responsive elements. Can distinguish agonism from antagonism.
      • Tox21_AR_BLA_Agonist_ratio A cell based assay with an inducible reporter. Can distinguish agonists from antagonists.
      • Tox21_AR_LUC_MDAKB2_agonist A cell based assay with an inducible reporter. Can distinguish agonists from antagonists.
    • Assay descriptions

References

  • Ankley GT, Gray LE. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Environ Toxicol Chem. 2013 Apr;32(5):1084-7. doi: 10.1002/etc.2151. Epub 2013 Mar 19. PubMed PMID: 23401061.
  • Ankley GT, Jensen KM, Kahl MD, Durhan EJ, Makynen EA, Cavallin JE, Martinović D, Wehmas LC, Mueller ND, Villeneuve DL. Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model. Aquat Toxicol. 2010 Sep 1;99(3):389-96. doi: 10.1016/j.aquatox.2010.05.020. Epub 2010 Jun 4. PubMed PMID: 20573408.
  • Ankley GT, Jensen KM, Makynen EA, Kahl MD, Korte JJ, Hornung MW, Henry TR, Denny JS, Leino RL, Wilson VS, Cardon MC, Hartig PC, Gray LE. Effects of the androgenic growth promoter 17-beta-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. Environ Toxicol Chem. 2003 Jun;22(6):1350-60. PubMed PMID: 12785594.
  • Araki N, Ohno K, Nakai M, Takeyoshi M, Iida M. 2005. Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells. Toxicology in vitro : an international journal published in association with BIBRA 19(6): 831-842.
  • Bain PA, Ogino Y, Miyagawa S, Iguchi T, Kumar A. Differential ligand selectivity of androgen receptors α and β from Murray-Darling rainbowfish (Melanotaenia fluviatilis). Gen Comp Endocrinol. 2015 Feb 1;212:84-91. doi: 10.1016/j.ygcen.2015.01.024. PubMed PMID: 25644213.
  • Baker ME. 1997. Steroid receptor phylogeny and vertebrate origins. Molecular and cellular endocrinology 135(2): 101-107.
  • Bohl CE, Chang C, Mohler ML, Chen J, Miller DD, Swaan PW, et al. 2004. A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor. Journal of medicinal chemistry 47(15): 3765-3776.
  • Centenera MM, Harris JM, Tilley WD, Butler LM. 2008. The contribution of different androgen receptor domains to receptor dimerization and signaling. Molecular endocrinology 22(11): 2373-2382.
  • Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C, Haelens A. 2008. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nuclear receptor signaling 6: e008.
  • Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE. 2008. Structural basis for the nuclear import of the human androgen receptor. Journal of cell science 121(Pt 7): 957-968.
  • Douard V, Brunet F, Boussau B, Ahrens-Fath I, Vlaeminck-Guillem V, Haendler B, Laudet V, Guiguen Y. The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event? BMC Evol Biol. 2008 Dec 18;8:336. doi: 10.1186/1471-2148-8-336. PubMed PMID: 19094205
  • Eick GN, Thornton JW. 2011. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Molecular and cellular endocrinology 334(1-2): 31-38.
  • Hahlbeck E, Katsiadaki I, Mayer I, Adolfsson-Erici M, James J, Bengtsson BE. The juvenile three-spined stickleback (Gasterosteus aculeatus L.) as a model organism for endocrine disruption II--kidney hypertrophy, vitellogenin and spiggin induction. Aquat Toxicol. 2004 Dec 20;70(4):311-26
  • Hong H, Fang H, Xie Q, Perkins R, Sheehan DM, Tong W. 2003. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor. SAR and QSAR in environmental research 14(5-6): 373-388.
  • Jakobsson, S., Borg, B., Haux, C. et al. Fish Physiology and Biochemistry (1999) 20: 79. doi:10.1023/A:1007776016610
  • Jensen KM, Makynen EA, Kahl MD, Ankley GT. Effects of the feedlot contaminant 17alpha-trenbolone on reproductive endocrinology of the fathead minnow. Environ Sci Technol. 2006 May 1;40(9):3112-7. PubMed PMID: 16719119.
  • Jolly C, Katsiadaki I, Le Belle N, Mayer I, Dufour S. 2006. Development of a stickleback kidney cell culture assay for the screening of androgenic and anti-androgenic endocrine disrupters. Aquatic toxicology 79(2): 158-166.
  • Kim TS, Yoon CY, Jung KK, Kim SS, Kang IH, Baek JH, et al. 2010. In vitro study of Organization for Economic Co-operation and Development (OECD) endocrine disruptor screening and testing methods- establishment of a recombinant rat androgen receptor (rrAR) binding assay. The Journal of toxicological sciences 35(2): 239-243.
  • LaLone CA, Villeneuve DL, Cavallin JE, Kahl MD, Durhan EJ, Makynen EA, Jensen KM, Stevens KE, Severson MN, Blanksma CA, Flynn KM, Hartig PC, Woodard JS, Berninger JP, Norberg-King TJ, Johnson RD, Ankley GT. Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone. Environ Toxicol Chem. 2013 Nov;32(11):2528-41. doi: 10.1002/etc.2330. Epub 2013 Sep 6. PubMed PMID: 23881739.
  • Mak P, Cruz FD, Chen S. 1999. A yeast screen system for aromatase inhibitors and ligands for androgen receptor: yeast cells transformed with aromatase and androgen receptor. Environmental health perspectives 107(11): 855-860.
  • Markov GV, Laudet V. 2011. Origin and evolution of the ligand-binding ability of nuclear receptors. Molecular and cellular endocrinology 334(1-2): 21-30.
  • Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, et al. 2009. Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chemistry & biology 16(4): 452-460.
  • OECD (2012), Test No. 229: Fish Short Term Reproduction Assay, OECD Publishing, Paris.
    DOI: http://dx.doi.org/10.1787/9789264185265-en
  • OECD (2016), Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals, OECD Publishing, Paris.
    DOI: http://dx.doi.org/10.1787/9789264264366-en
  • Olsson P-E, Berg A, von Hofsten J, Grahn B, Hellqvist A, Larsson A, et al. 2005. Molecular cloning and characterization of a nuclear androgen receptor activated by 11-ketotestosterone. Reproductive Biology and Endocrinology 3: 1-17.
  • Prescott J, Coetzee GA. 2006. Molecular chaperones throughout the life cycle of the androgen receptor. Cancer letters 231(1): 12-19.
  • Serafimova R, Walker J, Mekenyan O. 2002. Androgen receptor binding affinity of pesticide "active" formulation ingredients. QSAR evaluation by COREPA method. SAR and QSAR in environmental research 13(1): 127-134.
  • Sone K, Hinago M, Itamoto M, Katsu Y, Watanabe H, Urushitani H, Tooi O, Guillette LJ Jr, Iguchi T. Effects of an androgenic growth promoter 17beta-trenbolone on masculinization of Mosquitofish (Gambusia affinis affinis). Gen Comp Endocrinol. 2005 Sep 1;143(2):151-60. Epub 2005 Apr 13. PubMed PMID: 16061073.
  • Sperry TS, Thomas P. 1999. Identification of two nuclear androgen receptors in kelp bass (Paralabrax clathratus) and their binding affinities for xenobiotics: comparison with Atlantic croaker (Micropogonias undulatus) androgen receptors. Biology of reproduction 61(4): 1152-1161.
  • Stanko JP, Angus RA. In vivo assessment of the capacity of androstenedione to masculinize female mosquitofish (Gambusia affinis) exposed through dietary and static renewal methods. Environ Toxicol Chem. 2007 May;26(5):920-6. PubMed PMID: 17521138.
  • Thornton JW. 2001. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proceedings of the National Academy of Sciences of the United States of America 98(10): 5671-5676.
  • Tilley WD, Marcelli M, Wilson JD, McPhaul MJ. 1989. Characterization and expression of a cDNA encoding the human androgen receptor. Proceedings of the National Academy of Sciences of the United States of America 86(1): 327-331.
  • Todorov M, Mombelli E, Ait-Aissa S, Mekenyan O. 2011. Androgen receptor binding affinity: a QSAR evaluation. SAR and QSAR in environmental research 22(3): 265-291.
  • van der Burg B, Winter R, Man HY, Vangenechten C, Berckmans P, Weimer M, et al. 2010. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. Reproductive toxicology 30(1): 18-24.
  • Waller CL, Juma BW, Gray EJ, Kelce WR. 1996. Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicology and Applied Pharmacolgy 137: 219-227.
  • Wilson VS, Bobseine K, Lambright CR, Gray LE. 2002. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences 66: 69-81.
  • Wilson VS, Cardon MC, Gray LE, Jr., Hartig PC. 2007. Competitive binding comparison of endocrine-disrupting compounds to recombinant androgen receptor from fathead minnow, rainbow trout, and human. Environmental toxicology and chemistry / SETAC 26(9): 1793-1802.
  • Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, et al. 2003. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Molecular pharmacology 63(1): 211-223.

List of Key Events in the AOP

Event: 1790: Increased, Differentiation to Testis

Short Name: Increased, Differentiation to Testis

Key Event Component

Process Object Action
male gonad development immature gonad increased

AOPs Including This Key Event

Biological Context

Level of Biological Organization
Tissue

Organ term

Organ term
testis

Domain of Applicability

Taxonomic Applicability
Term Scientific Term Evidence Links
Vertebrates Vertebrates Moderate NCBI
Life Stage Applicability
Life Stage Evidence
Development Moderate
Sex Applicability
Sex Evidence
Male Moderate

The primordial gonad, the key genes for testicular differentiation and the structural morphology of the testes are highly conserved among vertebrates. Consequentially, this key even is applicable to most vertebrate taxa. 

 

Key Event Description

Prior to sex determination in many vertebrates, the developing organism have a bipotential gonad that can be fated to either sex depending on the genetic makeup of the embryo (genetic sex determination), environmental conditions (environmental sex determination) or both.Among vertebrates, the primordial gonad and the structural morphology of the testes are highly conserved. 

During male development, the embryonic stem cells can differentiate to primordial germ cells, which in turn proliferate and differentiate into precursor spermatogonia stem cells. Sertoli cells are the first cells to differentiate into the different fetal gonad seminiferous cords surrounded by peritubular myoid cells and enclosing fetal germ cells.  Sertoli cells can also differentiate into leydig cells. Successively, the interstitial Leydig cells differentiate and produce testosterone to induce masculinization (Fisher et al., 2003)

Although the timing and location of gene expression leading to this morphological development of the testis may differ among taxa, many vertebrate taxa share a common set of genes crucial for the testis differentiation pathway to be activated and be maintained. In most mammals, the autosomal gene SOX9 is first upregulated in the precursor Sertoli cells, which are important for proper testicular development and function. SOX9 works with fibroblast growth factor 9 (FGF9) in a feed-forward loop that represses female pathway genes such as the wnt family member 4 WNT4 an in turn maintaining the male pathway. After sex determination has been established, expression of DMRT1 (double- sex and mab-related transcription factor 1) in the developing gonads (during the downstream events of the testicular differentiation pathway) has been linked to proper development and maintenance of male gonads. For birds, it has been confirmed that DMRT1 is the bird sex- determining gene whereas for most mammals, the SRY gene initiates the testis determining molecular cascade (Marshall Graves et al., 2010; Trukhina et al., 2013). 

How it is Measured or Detected

Histological examination by light microscopy are performed to identify the phenotypic sex characteristics. In general, phenotypic males in early development will show three main differentiating cell types; the gamete forming cells (spermatogonia), support cells (Sertoli cells) and hormone secreting cells (Leydig or interstitial cells).

References

Capel, Blanche. (2017). Vertebrate sex determination: Evolutionary plasticity of a fundamental switch. Nature Reviews Genetics. 18. 10.1038/nrg.2017.60. 

Cutting, A., Chue, J., & Smith, C. A. (2013). Just how conserved is vertebrate sex determination?. Developmental dynamics : an official publication of the American Association of Anatomists, 242(4), 380–387. 

 DeFalco T, Capel B. Gonad morphogenesis in vertebrates: divergent means to a convergent end. Annu Rev Cell Dev Biol. 2009;25:457-482. doi:10.1146/annurev.cellbio.042308.13350

Marshall Graves, J. A., & Peichel, C. L. (2010). Are homologies in vertebrate sex determination due to shared ancestry or to limited options?. Genome biology, 11(4), 205. https://doi.org/10.1186/gb-2010-11-4-205

McLaren A. (1998). Gonad development: assembling the mammalian testis. Current biology : CB8(5), R175–R177. https://doi.org/10.1016/s0960-9822(98)70104-6

Nishimura, T., & Tanaka, M. (2014). Gonadal development in fish. Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation8(5), 252–261. 

Santos, D., Luzio, A., & Coimbra, A. M. (2017). Zebrafish sex differentiation and gonad development: A review on the impact of environmental factors. Aquatic toxicology (Amsterdam, Netherlands)191, 141–163. 

Trukhina, A. V., Lukina, N. A., Wackerow-Kouzova, N. D., & Smirnov, A. F. (2013). The variety of vertebrate mechanisms of sex determination. BioMed research international, 2013, 587460. https://doi.org/10.1155/2013/587460

Event: 1791: Increased, Male Biased Sex Ratio

Short Name: Increased, Male Biased Sex Ratio

Key Event Component

Process Object Action
male sex differentiation population of organisms increased

AOPs Including This Key Event

Biological Context

Level of Biological Organization
Population

Domain of Applicability

Life Stage Applicability
Life Stage Evidence
Adults High
Sex Applicability
Sex Evidence
Male High

This key event is applicable to most non-mammalian vertebrates that exhibit environmental sex determination as their primary form of sex determination. Vertebrates with genetic sex determination as their primary form of sex determination but that often times exhibit sexual plasticity towards environmental conditions in their early sex determination stages resulting in a phenotypic sex different from the chromosomal and genetic make-up can be included in this key event. 

Key Event Description

Animals that exhibit environmental sex determination (ESD) are often at risk of sex ratios being skewed toward a particular sex depending on the environmental conditions in which organisms are exposed during early developmental stages (Ospina-Alvarez et al., 2008;Stewart et al., 2014). This process is particular to every species with ESD as the conditions necessary for the development of either male or female gonads can vary among taxa.  Exposure during the critical period of sex differentiation to environmentalconditions that lead offspring sex determination towards a male gonad differentiation pathway is capable of producing sex ratio alterations. Persistence of such male-producing environmental conditions for prolonged periods of times can result in a male‐biased allocation among structured habitats for a given population (Brown et al., 2015). 

References

Brown, A. R., Owen, S. F., Peters, J., Zhang, Y., Soffker, M., Paull, G. C., Hosken, D. J., Wahab, M. A., & Tyler, C. R. (2015). Climate change and pollution speed declines in zebrafish populations. Proceedings of the National Academy of Sciences of the United States of America112(11), E1237–E1246. 

Canesini, G.; Ramos, J.G.; Muñoz de Toro, Monica, M.(2018) Determinación sexual y diferenciación gonadal en Yacaré overo. Genes involucrados en su regulación y efecto de la exposición a perturbadores endocrinos. (Unpublished Doctoral Thesis). Universidad Nacional Del Litoral

Ospina-Alvarez, N., & Piferrer, F. (2008). Temperature-dependent sex determination in fish revisited: prevalence, a single sex ratio response pattern, and possible effects of climate change. PloS one3(7), e2837. 

Stewart, K. R., & Dutton, P. H. (2014). Breeding sex ratios in adult leatherback turtles (Dermochelys coriacea) may compensate for female-biased hatchling sex ratios. PloS one9(2), e88138. https://doi.org/10.1371/journal.pone.0088138

List of Adverse Outcomes in this AOP

Event: 360: Decrease, Population trajectory

Short Name: Decrease, Population trajectory

Key Event Component

Process Object Action
population growth rate population of organisms decreased

AOPs Including This Key Event

AOP ID and Name Event Type
Aop:23 - Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish) AdverseOutcome
Aop:25 - Aromatase inhibition leading to reproductive dysfunction AdverseOutcome
Aop:29 - Estrogen receptor agonism leading to reproductive dysfunction AdverseOutcome
Aop:30 - Estrogen receptor antagonism leading to reproductive dysfunction AdverseOutcome
Aop:100 - Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior AdverseOutcome
Aop:122 - Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation AdverseOutcome
Aop:123 - Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription AdverseOutcome
Aop:155 - Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation AdverseOutcome
Aop:156 - Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation AdverseOutcome
Aop:157 - Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation AdverseOutcome
Aop:158 - Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation AdverseOutcome
Aop:159 - Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation AdverseOutcome
Aop:101 - Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release AdverseOutcome
Aop:102 - Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition AdverseOutcome
Aop:63 - Cyclooxygenase inhibition leading to reproductive dysfunction AdverseOutcome
Aop:103 - Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint AdverseOutcome
Aop:292 - Inhibition of tyrosinase leads to decreased population in fish AdverseOutcome
Aop:310 - Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR AdverseOutcome
Aop:16 - Acetylcholinesterase inhibition leading to acute mortality AdverseOutcome
Aop:312 - Acetylcholinesterase Inhibition leading to Acute Mortality via Impaired Coordination & Movement​ AdverseOutcome
Aop:334 - Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration AdverseOutcome
Aop:336 - DNA methyltransferase inhibition leading to population decline (1) AdverseOutcome
Aop:337 - DNA methyltransferase inhibition leading to population decline (2) AdverseOutcome
Aop:338 - DNA methyltransferase inhibition leading to population decline (3) AdverseOutcome
Aop:339 - DNA methyltransferase inhibition leading to population decline (4) AdverseOutcome
Aop:340 - DNA methyltransferase inhibition leading to transgenerational effects (1) AdverseOutcome
Aop:341 - DNA methyltransferase inhibition leading to transgenerational effects (2) AdverseOutcome
Aop:289 - Inhibition of 5α-reductase leading to impaired fecundity in female fish AdverseOutcome
Aop:297 - Inhibition of retinaldehyde dehydrogenase leads to population decline AdverseOutcome
Aop:346 - Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation AdverseOutcome
Aop:299 - Excessive reactive oxygen species production leading to population decline via reduced fatty acid beta-oxidation AdverseOutcome
Aop:311 - Excessive reactive oxygen species production leading to population decline via mitochondrial dysfunction AdverseOutcome
Aop:216 - Excessive reactive oxygen species production leading to population decline via follicular atresia AdverseOutcome
Aop:238 - Excessive reactive oxygen species production leading to population decline via lipid peroxidation AdverseOutcome
Aop:326 - Thermal stress leading to population decline (3) AdverseOutcome
Aop:325 - Thermal stress leading to population decline (2) AdverseOutcome
Aop:324 - Thermal stress leading to population decline (1) AdverseOutcome
Aop:363 - Thyroperoxidase inhibition leading to increased mortality via altered retinal layer structure AdverseOutcome
Aop:349 - Inhibition of 11β-hydroxylase leading to decresed trajectory in fish AdverseOutcome
Aop:348 - Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased trajectory in fish AdverseOutcome
Aop:376 - Androgen receptor agonism leading to male-biased sex ratio AdverseOutcome
Aop:386 - Increased reactive oxygen species production leading to population decline via inhibition of photosynthesis AdverseOutcome
Aop:387 - Increased reactive oxygen species production leading to population decline via mitochondrial dysfunction AdverseOutcome
Aop:388 - DNA damage leading to population decline via programmed cell death AdverseOutcome
Aop:389 - Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis AdverseOutcome
Aop:364 - Thyroperoxidase inhibition leading to increased mortality via decreased eye size AdverseOutcome
Aop:365 - Thyroperoxidase inhibition leading to increased mortality via altered photoreceptor patterning AdverseOutcome
Aop:399 - Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos) AdverseOutcome

Biological Context

Level of Biological Organization
Population

Domain of Applicability

Taxonomic Applicability
Term Scientific Term Evidence Links
all species all species High NCBI
Life Stage Applicability
Life Stage Evidence
All life stages Not Specified
Sex Applicability
Sex Evidence
Unspecific Not Specified

Consideration of population size and changes in population size over time is potentially relevant to all living organisms.

Key Event Description

Maintenance of sustainable fish and wildlife populations (i.e., adequate to ensure long-term delivery of valued ecosystem services) is an accepted regulatory goal upon which risk assessments and risk management decisions are based.

How it is Measured or Detected

Population trajectories, either hypothetical or site specific, can be estimated via population modeling based on measurements of vital rates or reasonable surrogates measured in laboratory studies. As an example, Miller and Ankley 2004 used measures of cumulative fecundity from laboratory studies with repeat spawning fish species to predict population-level consequences of continuous exposure.

Regulatory Significance of the AO

Maintenance of sustainable fish and wildlife populations (i.e., adequate to ensure long-term delivery of valued ecosystem services) is a widely accepted regulatory goal upon which risk assessments and risk management decisions are based.

References

  • Miller DH, Ankley GT. 2004. Modeling impacts on populations: fathead minnow (Pimephales promelas) exposure to the endocrine disruptor 17ß-trenbolone as a case study. Ecotoxicology and Environmental Safety 59: 1-9.

Appendix 2

List of Key Event Relationships in the AOP